The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

Biogen and City Therapeutics have announced a partnership worth over $1bn to develop new RNAi therapies. The collaboration ...

Biogen partners with City Therapeutics to develop select novel RNAi-based therapies: Cambridge, Massachusetts Thursday, May 29, 2025, 10:00 Hrs [IST] Biogen Inc, a leading biotech ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.

Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.

A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments.

Healthcare companies rose as traders mulled the latest tariff headlines amid higher-than-expected May consumer confidence. Shares of Hologic advanced 15% after the Financial Times reported the company ...

University of Michigan spinoff company Courage Therapeutics is based in Massachusetts and develops medicines targeting ...

Biogen ( NASDAQ: BIIB) and City Therapeutics signed a collaboration to develop novel RNA interference ( (RNAi)) therapies ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Biotech major Biogen (Nasdaq: BIIB) and fellow Cambridge, USA-based City Therapeutics, today announced a strategic ...